	Radiotherapy and Cardiovascular Disease Survival Risk in Non-Small Cell Lung Cancer: A Population-Based Study From the Surveillance, Epidemiology, and End Results Database. Cancer Med Liu L, Fan C, Ren W, Wen M, Li C, Hao C, Geng Y, Zhang L. PMID: 42286978 [PubMed - in process]
	Paraneoplastic neurologic syndrome in advanced lung cancer with mixed adenocarcinoma and squamous features: a diagnostic challenge-a case report. J Med Case Rep Malangwa G, Mushengezi B, Lyatuu L, Mwapule L, Mosha I, Hondo A, Mashaka AB, Nyanza B, Mgomi M, Kessy A, Tamambele M, Kassim Z, Macha C, Antanamsu D, Katwana D, Mungulluh F, Miyanga F, Massawe J, Assenga GA, Malangwa GF, Ndakama P, Joseph S, Abeid WS, Myaka E, Moshi S, Maige GG, Fulano KB, Mosha M, Kalunga ME, Kilawa SI, Lubinza C, Mazengo DS, Mkama RE, Lema GS, Msemo D. PMID: 42286636 [PubMed - as supplied by publisher]
	The perioperative effect of ERAS protocol in patients with lung cancer: a randomized controlled study. J Cardiothorac Surg Xiao D, Deng P, Feng Z, Yao C, Yuan B. PMID: 42286588 [PubMed - as supplied by publisher]
	Cadonilimab plus chemotherapy as first-line treatment in PD-L1-negative advanced non-small cell lung cancer: a phase II clinical trial. Nat Commun Wang L, Rao C, Wang Q, Huang K, Liu L, Zhao J, Wu Y, Chen J, Qian J, Lu H, Pan S, Nie L, Tang H, Dong H, Jia SD, Zang Y, Chu T, Su C. PMID: 42285994 [PubMed - as supplied by publisher]
	Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non-Small Cell Lung Cancer. Cancer Sci Teramoto K, Kaku R, Igarashi T, Hashimoto M, Kitamura S, Motoishi M, Suzumura Y, Sawai S, Daigo Y, Hanaoka J. PMID: 42285905 [PubMed - as supplied by publisher]
	RRBP1 promotes osimertinib resistance by activating fatty acid oxidation-dependent metabolic and immune reprogramming in EGFR-Mutant lung adenocarcinoma. Biochem Pharmacol Huang Y, Zhang Y. PMID: 42285369 [PubMed - as supplied by publisher]
	Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation study. Cancer Lett Wang C, Dong X, Zhang G, Ren N, Chen X, Xie J, Shi X, Guo Z, Zheng Y, Luo Z, Zhu X, Cao W, Wang F, Tan F, Li N, He J. PMID: 42285215 [PubMed - as supplied by publisher]
	Molecular insights and therapeutic implications for the tumor suppressor role of LKB1 in Non-Small Cell Lung Cancer. Cancer Lett Yan P, Jiang W, Xue X, Hou T, Wang J, Huang D, Chen L, Inuzuka H, Dai X, Wei W. PMID: 42285213 [PubMed - as supplied by publisher]
	Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study. Cancer Treat Res Commun Samol J, Demedts I, Erman M, Kozlov V, Minatta JN, Moiseenko F, Mark M, Rajappa S, Bailey T, Wallis H, Servidio L, Kahangire DA, Zukin M. PMID: 42284848 [PubMed - as supplied by publisher]
	Predicting recurrence within 5 years in Early-Stage lung adenocarcinoma with micropapillary and solid patterns. Int J Med Inform Wang Z, Chen J, Xu Y, Lin T, Chen C, Shen Y, Huang J, Xu S, Chen S. PMID: 42284830 [PubMed - as supplied by publisher]
	Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020). JCO Precis Oncol Leonetti A, Pluchino M, Minari R, Passiglia F, Pizzutilo EG, Cortinovis DL, Toschi L, Gelsomino F, Frega S, Metro G, Belluomini L, Montrone M, Camerini A, Bertolini A, Baldini E, Mazzoni F, Bria E, Bertolini F, Del Conte A, Bordi P, Perrone F, Verzè M, D'Agnelli S, Onorini P, Cosenza A, Facchinetti F, Boni L, Tognetto M, Tiseo M. PMID: 42284541 [PubMed - indexed for MEDLINE]
	Classifying family resilience trajectory of patients undergoing lung cancer surgery: a longitudinal study. Support Care Cancer Gao SR, Zhu J, Yan H, Xu H, Wu XY, Luo GH, Li XT, Ye M. PMID: 42283863 [PubMed - indexed for MEDLINE]
	How Wide is the Screening Window for Aggressive Non-Small Cell Lung Cancers? The Cure Threshold Metric and its Implications for Lung Cancer Screening Guidelines. Cancer Epidemiol Biomarkers Prev Goldwasser DL. PMID: 42283747 [PubMed - as supplied by publisher]
	Predictors of clinically relevant postoperative morbidity following curative intent surgical resection for non-small cell lung cancer. J Med Life Tanase CB, Chitoran E, Rotaru V, Gullo G, Horvat T, Simion L. PMID: 42282223 [PubMed - indexed for MEDLINE]
	Female underrepresentation and adverse events reporting biases in lung cancer clinical trials: a systematic review and meta-analysis. J Natl Cancer Cent Gan Y, Tian R, Han S, Zeng H, Sun F. PMID: 42282126 [PubMed]
	Liquid Biopsy Biomarkers for Predicting and Monitoring Immunotherapy Response in Lung Cancer. Cancers (Basel) Serio VB, Regoli T, Frullanti E, Palmieri M. PMID: 42279422 [PubMed]
	Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic Markers. Cancers (Basel) Tannura F, Sbrana A, Chella A, Pistelli F, Carrozzi L, Celi A, Pancani R. PMID: 42279420 [PubMed]
	Molecular Analysis of EBUS-TBNA Samples for Nodal Staging in Non-Small Cell Lung Cancer. Cancers (Basel) Ehab A, Benabdallah N, Darwiche K. PMID: 42279379 [PubMed]
	Peripheral CD8+ T Cell Dynamics and Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Following Bronchoscopic Cryotherapy and Pembrolizumab-Based Therapy. Cancers (Basel) Vasiliauskas G, , Skrodenien, Po, Miliauskas S, . PMID: 42279375 [PubMed]
	N1 Staging in Non-Small Cell Lung Cancer: Current Situation, Limitations, and the Importance of Peripheral Nodal Assessment. Cancers (Basel) Ishiwata T. PMID: 42279374 [PubMed]

Articles 1 - 20 / 160396

Page 1 of 8020



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy